Innovative drug concept stocks are repeatedly active, CCHT has two consecutive limit-ups
Innovative drug concept stocks are repeatedly active, Mabwell and BeiGene hit new highs during the session, CCHT has two consecutive limit-ups, AmoyDx and Hicin Pharmaceutical rose over 10%, WECOME, Warner Pharmaceuticals, Nanxin Pharmaceutical, and Betta Pharmaceuticals followed suit
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments